|Articles|November 1, 2004
Risk awareness more important than ever for isotretinoin
New York - Discussing "What's Up with Isotretinoin" at the recent American Academy of Dermatology Academy '04 here, John S. Strauss, M.D., reported that much of the recent attention on oral retinoids continues to focus on the pregnancy risk management aspects of its use for the treatment of acne.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5













